Kindstar Globalgene Technology Inc

09960

Company Profile

  • Business description

    Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services in China. It organizes the business into the following segments; hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, scientific research services and CRO, and other segments provide testing services for R&D projects and others and miscellaneous services.

  • Contact

    Biolake D2-1, 666 Gaoxin Road
    East Lake High Tech Zone
    Hubei Province
    Wuhan
    CHN

    https://www.kindstar.com.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    3,193

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,365.7024.700.30%
CAC 407,593.8738.000.50%
DAX 4022,496.9871.150.32%
Dow JONES (US)40,752.9683.600.21%
FTSE 1008,496.801.950.02%
HKSE22,119.41111.300.51%
NASDAQ17,710.74264.401.52%
Nikkei 22536,452.30406.921.13%
NZX 50 Index12,148.60245.292.06%
S&P 5005,604.1435.080.63%
S&P/ASX 2008,145.6019.400.24%
SSE Composite Index3,279.037.62-0.23%

Market Movers